SUBSCRIBE
SUBSCRIBE
News   Drug Development

Genentech, Inc. Updates Colon Cancer Trial Timeline

January 21, 2009 | 
1 min read
BOSTON, Jan 21 (Reuters) - Genentech Inc said on Wednesday that results of a trial of its cancer drug Avastin in colon cancer patients who have undergone surgery could be known as early as mid-April this year.
Clinical research Phase III Postmarket research
Genentech, Inc.
MORE ON THIS TOPIC
Hand holding a lung shape symbol against a blue background. World tuberculosis day, world no tobacco day, lung cancer, pulmonary hypertension, pneumonia
Lung cancer
BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC
September 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Collage art of a hand touching a cat. Modern and creative design with surreal style. Perfect for use in posters, editorial design, social media, digital art, and contemporary art projects
Allergies
Regeneron’s Antibodies Block Cat and Birch Allergies With ‘Robust Activity’
September 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Modern data center with AI server racks connected by glowing blue lines, representing artificial intelligence, advanced computing, and data processing.
Drug Development
If Data Is the New Oil, AI Is the Refinery
September 8, 2025
 · 
5 min read
 · 
Lori Ellis
Contemporary art collage of woman sitting in the lotus position, cloud, pillows against the background of the night sky. Concept of healthy lifestyle and sport. Good and relaxing sleep. Copy space.
Neuroscience
Alkermes One Ups Takeda in Narcolepsy, Clearing Cognitive Impairments in Mid-Stage Trial
September 8, 2025
 · 
2 min read
 · 
Dan Samorodnitsky